Evidence map›Paper›PMID 40486302›Full record

ArticleCureus2025

DICER1 Mutation-Associated Follicular Thyroid Tumor With Bizarre and Pleomorphic Nuclei.

Mai Thy Tran, Hunter L Monroe, John A Ozolek, Reima El Naili

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Multimodal spectrum of approach in poorly differentiated thyroid carcinoma (an updated analysis).Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mai Thy TranPathology and Laboratory Medicine, West Virginia University School of Medicine, Morgantown, USA.
Hunter L MonroePathology, West Virginia University, Morgantown, USA.
John A OzolekPathology, Anatomy and Laboratory Medicine, West Virginia University School of Medicine, Morgantown, USA.
Reima El NailiPathology, Anatomy and Laboratory Medicine, West Virginia University School of Medicine, Morgantown, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid carcinomas comprise diverse subtypes, each characterized by distinct histomorphologies, molecular profiles, and prognoses. Follicular thyroid carcinoma (FTC) is a differentiated thyroid cancer demonstrating vascular and/or capsular invasion, while anaplastic thyroid carcinoma (ATC) is an aggressive and undifferentiated form with an exceedingly dismal prognosis. Thyroid carcinomas also can exhibit mixed histologic features, complicating the diagnosis and management of these entities.

Indexed as

anaplastic thyroid carcinomasbizarre nucleidicer1 mutationfollicular thyroid carcinoma (ftc)thyroid carcinoma

Identifiers

PMID40486302
PMCPMC12142705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.